Improved prediction of the minimal phototoxic dose in PUVA therapy.
In an attempt to improve the prediction of PUVA erythemal sensitivity, we have examined, in 251 patients, the relationship between the minimal phototoxic dose (MPD) and a number of variables, including skin type, ingested dose of 8-methoxypsoralen (8-MOP) and history of previous PUVA treatment. The MPD was determined by phototesting 2 h after ingestion of crystalline 8-MOP, given at a standard dose of 0.6 mg/kg (calculated to the nearest 10 mg). No reaction to the highest dose of UVA used for phototesting occurred in 16% of cases; the dose of 8-MOP was significantly associated with non-response. In the patients in whom an erythemal response was obtained, a significant association was found between the MPD and the variables of skin type, ingested dose of 8-MOP, and history of previous PUVA treatment. Thus, by taking these factors into account, a more accurate prediction can be made of an individual patient's erythemal sensitivity to PUVA than relying on skin type alone. That erythemal sensitivity is affected by the ingested dose of 8-MOP (even when all patients received 0.6 mg/kg) suggests that conventional psoralen dosing according to body weight is not ideal.
Sakuntabhai
A
A
Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne, U.K.
Matthews
J N
JN
Farr
P M
PM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017484:Dermatitis, Phototoxic / Q000209:etiology* / Q000473:pathology; D004334:Drug Administration Schedule; D005127:Eye Color; D005260:Female; D006200:Hair Color; D006801:Humans; D008297:Male; D008730:Methoxsalen / Q000008:administration & dosage; D008875:Middle Aged; D011701:PUVA Therapy / Q000009:adverse effects*; D012867:Skin / Q000473:pathology / Q000528:radiation effects
D008730:Methoxsalen